177 related articles for article (PubMed ID: 31292912)
41. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
[TBL] [Abstract][Full Text] [Related]
42. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
43. Co-occurrence of papillary thyroid carcinoma and primary lymphoma of the thyroid in a patient with long-standing Hashimoto's thyroiditis.
Cheng V; Brainard J; Nasr C
Thyroid; 2012 Jun; 22(6):647-50. PubMed ID: 22568399
[TBL] [Abstract][Full Text] [Related]
44. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
45. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
[TBL] [Abstract][Full Text] [Related]
46. Prevalence and aggressiveness of papillary thyroid carcinoma in surgically-treated graves' disease patients: a retrospective matched cohort study.
You E; Mascarella MA; Al Jassim A; Forest VI; Hier MP; Tamilia M; Pusztaszeri M; Payne RJ
J Otolaryngol Head Neck Surg; 2019 Aug; 48(1):40. PubMed ID: 31462328
[TBL] [Abstract][Full Text] [Related]
47. Inverse Relationship of BMI to TSH and Risk of Papillary Thyroid Cancer in Surgical Patients.
Handelsman RS; Alvarez AL; Picado O; Farrá JC; Lew JI
J Surg Res; 2019 Dec; 244():96-101. PubMed ID: 31280000
[TBL] [Abstract][Full Text] [Related]
48. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
[TBL] [Abstract][Full Text] [Related]
49. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
[TBL] [Abstract][Full Text] [Related]
50. Risk Factors for Central Neck Lymph Node Metastases in Micro- Versus Macro- Clinically Node Negative Papillary Thyroid Carcinoma.
Sessa L; Lombardi CP; De Crea C; Tempera SE; Bellantone R; Raffaelli M
World J Surg; 2018 Mar; 42(3):623-629. PubMed ID: 29238850
[TBL] [Abstract][Full Text] [Related]
51. Cervical thyroid remnant consistent with papillary carcinoma as an incidental finding in a patient with benign total thyroidectomy ten years prior.
Ruano Campos A; Rivera Alonso D; Ochagavía Cámara S
Pol Przegl Chir; 2019 Jul; 92(1):52-54. PubMed ID: 32312925
[TBL] [Abstract][Full Text] [Related]
52. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
53. Performing contralateral central lymph node dissection in papillary thyroid carcinoma: a decision approach.
Chae BJ; Jung CK; Lim DJ; Song BJ; Kim JS; Jung SS; Bae JS
Thyroid; 2011 Aug; 21(8):873-7. PubMed ID: 21745104
[TBL] [Abstract][Full Text] [Related]
54. Incidence of metastases from 524 patients with papillary thyroid carcinoma in cervical lymph nodes posterior to the sternoclavicular joint (level VIa): Relevance for endoscopic thyroidectomy.
Wang J; Gao L; Song C; Xie L
Surgery; 2016 Jun; 159(6):1557-1564. PubMed ID: 26923988
[TBL] [Abstract][Full Text] [Related]
55. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
56. Multifocality as independent prognostic factor in papillary thyroid cancer - A multivariate analysis.
Markovic I; Goran M; Besic N; Buta M; Djurisic I; Stojiljkovic D; Zegarac M; Pupic G; Inic Z; Dzodic R
J BUON; 2018; 23(4):1049-1054. PubMed ID: 30358210
[TBL] [Abstract][Full Text] [Related]
57. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study.
Cai YF; Wang QX; Ni CJ; Guo GL; Li Q; Wang OC; Wu L; Du HY; You J; Zhang XH
Medicine (Baltimore); 2015 Nov; 94(44):e1881. PubMed ID: 26554782
[TBL] [Abstract][Full Text] [Related]
58. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
59. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
60. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.
Kaserer K; Scheuba C; Neuhold N; Weinhäusel A; Vierhapper H; Haas OA; Niederle B
Am J Surg Pathol; 1998 Jun; 22(6):722-8. PubMed ID: 9630179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]